Central Trust Company’s Adeptus Health Inc ADPT Stock Holding History

Central Trust Company’s Portfolio ADPT Stock Details ADPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-600	Closed	-$31K	–	1209
2016 Q2	$31K	Buy	+600	New	+$36K	﹤0.01%	792

Other funds holding ADPT

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Axon Capital New York $69.3M AUM

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Central Trust Company's ADPT Position: Q3 2016 in Review

Central Trust Company sold out of Adeptus Health Inc (ADPT) in Q3 2016, closing a stake of 600 shares — an estimated $31K sold.

Central Trust Company first reported a position in ADPT in Q2 2016 and held it in 1 quarter. The position peaked at $31K in Q2 2016. 134 funds tracked by Wall St. Rank hold ADPT as of Q3 2016.

Central Trust Company reported no remaining Adeptus Health Inc position as of Q3 2016 after selling out during the quarter.
Central Trust Company sold 600 Adeptus Health Inc shares in Q3 2016, an estimated $31K.
Central Trust Company first reported a position in Adeptus Health Inc in Q2 2016 and held it in 1 quarter.
Central Trust Company's Adeptus Health Inc position peaked at $31K in Q2 2016.
134 funds tracked by Wall St. Rank held Adeptus Health Inc as of Q3 2016.

Based on Central Trust Company's 13F filing for Q3 2016, filed 24 Oct 2016.